IXICO Reports Fiscal 2026 Revenue Growth Above Guidance
IXICO reported fiscal-year revenue of £8.3 million, up 28% and above previous guidance. Its order book was £16.0 million, year-end cash was £10.4 million following a capital raise, and it expects loss before interest, tax, depreciation and amortisation to improve on market expectations.
IXICO PLC said its trading update for the fiscal year ending 30 September 2026 showed revenue of £8.3 million, up 28% and above its previous guidance. Its order book stands at £16.0 million, which the company said provides improved revenue visibility. Year-end cash reserves increased to £10.4 million after a capital raise. IXICO also expects its loss before interest, tax, depreciation and amortisation to be better than market expectations, while continuing to invest for growth.
Management attributed the performance to strong demand for its neuroimaging and digital biomarker analytics services.